News Published
"Encouraging to see the efficacy signals sustained at the highest dose level"
Isofol's Chief Medical Officer Roger Tell discusses the preliminary results from the ongoing phase Ib/II study.
News Published
Isofol's Chief Medical Officer Roger Tell discusses the preliminary results from the ongoing phase Ib/II study.